Top brokers name 3 ASX 200 shares to buy next week

Top brokers have named National Australia Bank Ltd (ASX:NAB) and these ASX 200 shares as buys for next week. Here's why they are bullish…

| More on:
watch

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week saw a large number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.

Here's why brokers think investors ought to buy them next week:

BHP Group Ltd (ASX: BHP)

According to a note out of Goldman Sachs, its analysts have retained their buy rating and lifted their price target on this mining giant's shares to $37.80. The broker lifted its price target to reflect higher than expected iron ore prices. In addition to this, it notes that BHP has a strong balance sheet and could use this for share buybacks or value-accretive acquisitions. It also likes the miner due to its strong free cash flow generation and high returning green/brownfield projects. I agree with Goldman Sachs and would be a buyer of its shares.

National Australia Bank Ltd (ASX: NAB)

Analysts at UBS have upgraded this banking giant's shares to a buy rating with an improved price target of $20.50. According to the note, the broker believes that the outlook for the banks is not as bleak as it looked just a few weeks ago. In light of this, it sees value in NAB's shares after they underperformed the market during the crisis. I agree with UBS and think NAB and the rest of the big four banks look good value at present.

Qantas Airways Limited (ASX: QAN)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $5.20 price target on this airline operator's shares. This follows an announcement by Qantas that its domestic capacity could be back to upwards of 40% of pre-pandemic levels by the end of July. It also notes that there is speculation that international travel between Australia and New Zealand could commence from next month. This would be a positive. As long as there is no second wave, I think Qantas could be a good option for investors.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two people shaking hands in the boardroom on a merger.
Share Market News

Champion Iron raises US$100 million for Rana Gruber acquisition

Champion Iron raised US$100 million from La Caisse to fund its acquisition push for Rana Gruber, increasing La Caisse’s stake…

Read more »

Work meeting among a diverse group of colleagues.
Share Market News

Elders appoints René Dedoncker as next CEO in planned succession

Elders appoints René Dedoncker as next CEO, with Mark Allison supporting a well-planned succession until 2027.

Read more »

Woman with gold nuggets on her hand.
Broker Notes

Why this surging ASX 300 gold stock is forecast to keep on giving

A leading broker forecasts more outperformance from this rocketing ASX gold stock.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Credit Corp, PLS, and ResMed shares

Let's see what Morgans is saying about these shares this week.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Dividend Investing

Passive income: How much do you need to invest to make $500 per month?

This is how much you’d need to unlock significant passive income.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

Scientists working in the laboratory and examining results.
Share Market News

Neuren Pharmaceuticals shares FDA meeting feedback on NNZ-2591 clinical programs

Neuren shares FDA feedback on NNZ-2591 development plans in HIE and PTHS, with next steps and management insights.

Read more »

View of a business man's hand passing a $100 note to another with a bank in the background.
Opinions

3 ASX shares I'd buy with $10,000 today

Here's where I'd put $10,000 right now.

Read more »